title: Response to Suarez-Kurtz's comments on strongly increased exposure of meloxicam in CYP2C9*3/*3 individuals.
authors.affiliation: aDepartment of Pharmacology, School of Pharmacy, Sungkyunkwan University, Suwon bDepartment of Pharmacology, College of Pharmacy, Keimyung University, Daegu cDepartment of Pharmacotherapy, College of Pharmacy, Dongguk University, Goyang dDepartment of Pharmacotherapy, College of Pharmacy, Dankook University, Cheonan, Republic of Korea.
authors.forename: Hye-In
authors.initials: HI
authors.lastname: Lee
authors.forename: Jung-Woo
authors.initials: JW
authors.lastname: Bae
authors.forename: Chang-Ik
authors.initials: CI
authors.lastname: Choi
authors.forename: Yun-Jeong
authors.initials: YJ
authors.lastname: Lee
authors.forename: Ji-Yeong
authors.initials: JY
authors.lastname: Byeon
authors.forename: Choon-Gon
authors.initials: CG
authors.lastname: Jang
authors.forename: Seok-Yong
authors.initials: SY
authors.lastname: Lee
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D006801:Humans; D008297:Male; D013843:Thiazines / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D013844:Thiazoles / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D013929:Thromboxane B2 / Q000097:blood*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D013843:Thiazines; D013844:Thiazoles; D013929:Thromboxane B2; D001189:Aryl Hydrocarbon Hydroxylases